Patient-derived parathyroid organoids as a tracer and drug-screening application model

Milou E. Noltes, Luc H.J. Sondorp, Laura Kracht, Inês F. Antunes, René Wardenaar, Wendy Kelder, Annelies Kemper, Wiktor Szymanski, Wouter T. Zandee, Liesbeth Jansen, Adrienne H. Brouwers, Robert P. Coppes*, Schelto Kruijff

*Corresponding author voor dit werk

Onderzoeksoutput: ArticleAcademicpeer review

10 Citaten (Scopus)
178 Downloads (Pure)

Samenvatting

Parathyroid diseases are characterized by dysregulation of calcium homeostasis and alterations in parathyroid hormone (PTH) excretion. The development of parathyroid-targeted treatment and imaging tracers could benefit from in vitro models. Therefore, we aim to establish a patient-derived parathyroid organoid model representing human parathyroid tissue. Hyperplastic parathyroid tissue was dispersed, and parathyroid organoids (PTOs) were cultured and characterized. PTO-derived cells exhibited self-renewal over several passages, indicative of the presence of putative stem cells. Immunofluorescence and RNA sequencing confirmed that PTOs phenocopy hyperplastic parathyroid tissue. Exposure of PTOs to increasing calcium concentrations and PTH-lowering drugs resulted in significantly reduced PTH excretion. PTOs showed specific binding of the imaging tracers 11C-methionine and 99mTc-sestamibi. These data show the functionality of PTOs resembling the parathyroid. This PTO model recapitulates the originating tissue on gene and protein expression and functionality, paving the way for future physiology studies and therapeutic target and tracer discovery.

Originele taal-2English
Pagina's (van-tot)2518-2530
Aantal pagina's13
TijdschriftStem Cell Reports
Volume17
Nummer van het tijdschrift11
DOI's
StatusPublished - 8-nov.-2022

Vingerafdruk

Duik in de onderzoeksthema's van 'Patient-derived parathyroid organoids as a tracer and drug-screening application model'. Samen vormen ze een unieke vingerafdruk.

Citeer dit